IDEXX Laboratories (IDXX) Stock Forecast, Price Target & Predictions
IDXX Stock Forecast
IDEXX Laboratories (IDXX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $479.75, with a high of $600.00 and a low of $247.00. This represents a 11.82% increase from the last price of $429.03.
IDXX Stock Rating
IDEXX Laboratories stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
IDXX Price Target Upside V Benchmarks
Type | Name | Upside |
---|---|---|
Stock | IDEXX Laboratories | 11.82% |
Sector | Healthcare Stocks | 22.99% |
Industry | Diagnostics & Research Stocks | 28.17% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $510.00 |
Last Closing Price | $429.03 | $429.03 | $429.03 |
Upside/Downside | - | - | 18.87% |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Mar, 25 | 4 | 3 | 6 | - | 1 | 14 |
Feb, 25 | 4 | 3 | 7 | - | 1 | 15 |
Jan, 25 | 4 | 3 | 6 | - | 1 | 14 |
Dec, 24 | 4 | 3 | 6 | - | 2 | 15 |
Nov, 24 | 4 | 2 | 5 | 1 | 2 | 14 |
Analyst Price Target Forecasts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 24, 2024 | Jonathan Block | Stifel Nicolaus | $510.00 | $495.73 | 2.88% | 18.87% |
Feb 08, 2023 | Barclays | $590.00 | $507.68 | 16.21% | 37.52% | |
Feb 07, 2023 | J.P. Morgan | $550.00 | $487.04 | 12.93% | 28.20% | |
Feb 07, 2023 | Atlantic Equities | $600.00 | $485.53 | 23.58% | 39.85% | |
Feb 02, 2023 | Oppenheimer | $247.00 | $483.20 | -48.88% | -42.43% | |
Feb 02, 2023 | Citigroup | $268.00 | $483.20 | -44.54% | -37.53% | |
Dec 09, 2022 | Citigroup | $273.00 | $420.63 | -35.10% | -36.37% | |
Nov 15, 2022 | Morgan Stanley | $543.00 | $435.78 | 24.60% | 26.56% | |
Jun 24, 2022 | Stifel Nicolaus | $500.00 | $355.62 | 40.60% | 16.54% | |
May 19, 2022 | Goldman Sachs | $530.00 | $357.33 | 48.32% | 23.53% |
Analyst Rating Forecasts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Feb 04, 2025 | Barclays | Overweight | Overweight | hold |
Jul 25, 2024 | BTIG | Buy | initialise | |
Feb 08, 2023 | Barclays | Overweight | Overweight | hold |
Feb 07, 2023 | Atlantic Equities | Overweight | Overweight | hold |
Feb 02, 2023 | Oppenheimer | Outperform | Outperform | hold |
Feb 02, 2023 | Citigroup | Buy | Buy | hold |
Dec 09, 2022 | Citigroup | Buy | Buy | hold |
Nov 15, 2022 | Morgan Stanley | Overweight | Overweight | hold |
Jul 21, 2022 | Goldman Sachs | Neutral | Buy | upgrade |
May 19, 2022 | Goldman Sachs | Neutral | Neutral | hold |
Financial Forecast
EPS Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $6.82 | $8.74 | $8.12 | $10.17 | $10.79 | - | - | - | - |
Avg Forecast | $6.10 | $8.38 | $7.91 | $9.86 | $10.46 | $11.97 | $13.55 | $15.48 | $16.93 |
High Forecast | $6.19 | $8.50 | $7.99 | $9.92 | $10.54 | $12.22 | $14.03 | $16.33 | $17.13 |
Low Forecast | $6.04 | $8.30 | $7.82 | $9.81 | $10.40 | $11.75 | $12.84 | $14.21 | $16.70 |
Surprise % | 11.80% | 4.30% | 2.65% | 3.14% | 3.15% | - | - | - | - |
Revenue Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $2.71B | $3.22B | $3.37B | $3.66B | $3.90B | - | - | - | - |
Avg Forecast | $2.67B | $3.19B | $3.36B | $3.65B | $3.88B | $4.15B | $4.51B | $4.95B | $5.39B |
High Forecast | $2.70B | $3.23B | $3.38B | $3.66B | $3.89B | $4.18B | $4.52B | $4.95B | $5.44B |
Low Forecast | $2.65B | $3.17B | $3.33B | $3.64B | $3.84B | $4.12B | $4.50B | $4.94B | $5.34B |
Surprise % | 1.49% | 0.65% | 0.28% | 0.33% | 0.49% | - | - | - | - |
Net Income Forecast
Annual
Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|---|---|---|
Reported | $581.78M | $744.85M | $679.09M | $845.04M | $887.87M | - | - | - | - |
Avg Forecast | $418.39M | $604.02M | $662.67M | $845.04M | $878.93M | $1.01B | $1.10B | $1.22B | $1.42B |
High Forecast | $502.06M | $724.83M | $795.20M | $1.01B | $884.81M | $1.03B | $1.18B | $1.37B | $1.44B |
Low Forecast | $334.71M | $483.22M | $530.13M | $676.03M | $873.04M | $986.97M | $1.08B | $1.19B | $1.40B |
Surprise % | 39.05% | 23.31% | 2.48% | - | 1.02% | - | - | - | - |